Stephen Jensik to Recombinant Fusion Proteins
This is a "connection" page, showing publications Stephen Jensik has written about Recombinant Fusion Proteins.
Connection Strength
0.163
-
YSPSL (rPSGL-Ig) for improvement of early renal allograft function: a double-blind, placebo-controlled, multi-center Phase IIa study. Clin Transplant. 2011 Jul-Aug; 25(4):523-33.
Score: 0.091
-
Renal function with cyclosporine C2 monitoring, enteric-coated mycophenolate sodium and basiliximab: a 12-month randomized trial in renal transplant recipients. Clin Transplant. 2007 Mar-Apr; 21(2):192-201.
Score: 0.072